These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31273348)

  • 1. Greeting Messages from President of Japanese Society of Hypertension (JSH) The challenge of JSH: moonshot for "Conquest of hypertension in Japan".
    Itoh H
    Hypertens Res; 2019 Jul; 42(7):925-927. PubMed ID: 31273348
    [No Abstract]   [Full Text] [Related]  

  • 2. [The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2004)].
    Saruta T
    Nihon Rinsho; 2005 Jun; 63(6):952-8. PubMed ID: 15948375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Awareness of the Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2000) and compliance to its recommendations: surveys in 2000 and 2004.
    Ikeda N; Hasegawa T; Hasegawa T; Saito I; Saruta T
    J Hum Hypertens; 2006 Apr; 20(4):263-6. PubMed ID: 16355118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009).
    Ogihara T; Kikuchi K; Matsuoka H; Fujita T; Higaki J; Horiuchi M; Imai Y; Imaizumi T; Ito S; Iwao H; Kario K; Kawano Y; Kim-Mitsuyama S; Kimura G; Matsubara H; Matsuura H; Naruse M; Saito I; Shimada K; Shimamoto K; Suzuki H; Takishita S; Tanahashi N; Tsuchihashi T; Uchiyama M; Ueda S; Ueshima H; Umemura S; Ishimitsu T; Rakugi H;
    Hypertens Res; 2009 Jan; 32(1):3-107. PubMed ID: 19300436
    [No Abstract]   [Full Text] [Related]  

  • 5. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2014).
    Shimamoto K; Ando K; Fujita T; Hasebe N; Higaki J; Horiuchi M; Imai Y; Imaizumi T; Ishimitsu T; Ito M; Ito S; Itoh H; Iwao H; Kai H; Kario K; Kashihara N; Kawano Y; Kim-Mitsuyama S; Kimura G; Kohara K; Komuro I; Kumagai H; Matsuura H; Miura K; Morishita R; Naruse M; Node K; Ohya Y; Rakugi H; Saito I; Saitoh S; Shimada K; Shimosawa T; Suzuki H; Tamura K; Tanahashi N; Tsuchihashi T; Uchiyama M; Ueda S; Umemura S;
    Hypertens Res; 2014 Apr; 37(4):253-390. PubMed ID: 24705419
    [No Abstract]   [Full Text] [Related]  

  • 6. The new Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2014): a giant undertaking.
    Lindholm LH; Carlberg B
    Hypertens Res; 2014 Apr; 37(4):391-2. PubMed ID: 24705437
    [No Abstract]   [Full Text] [Related]  

  • 7. Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004).
    Japanese Society of Hypertension
    Hypertens Res; 2006 Aug; 29 Suppl():S1-105. PubMed ID: 17366911
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of elderly hypertension based on various hypertension management guidelines--comparison between European and American guidelines and Japanese guidelines].
    Matsuoka H
    Nihon Rinsho; 2005 Jun; 63(6):945-51. PubMed ID: 15948374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strategies for improving the treatment and control of hypertension in Japan.
    Sakima A; Matayoshi T; Arima H
    J Hum Hypertens; 2024 Jun; 38(6):510-515. PubMed ID: 35660794
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in pharmacologic management of hypertension in Japan one year after the publication of the JSH 2000 guidelines. First Japanese Society of Hypertension.
    Saito I; Kawabe H; Tsujioka M; Hirose H; Shibata H
    Hypertens Res; 2002 Mar; 25(2):175-8. PubMed ID: 12047031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current prescription status of antihypertensive drugs in Japanese patients with hypertension: Analysis by type of comorbidities.
    Ishida T; Oh A; Hiroi S; Shimasaki Y; Tsuchihashi T
    Clin Exp Hypertens; 2019; 41(3):203-210. PubMed ID: 29781721
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2019).
    Umemura S; Arima H; Arima S; Asayama K; Dohi Y; Hirooka Y; Horio T; Hoshide S; Ikeda S; Ishimitsu T; Ito M; Ito S; Iwashima Y; Kai H; Kamide K; Kanno Y; Kashihara N; Kawano Y; Kikuchi T; Kitamura K; Kitazono T; Kohara K; Kudo M; Kumagai H; Matsumura K; Matsuura H; Miura K; Mukoyama M; Nakamura S; Ohkubo T; Ohya Y; Okura T; Rakugi H; Saitoh S; Shibata H; Shimosawa T; Suzuki H; Takahashi S; Tamura K; Tomiyama H; Tsuchihashi T; Ueda S; Uehara Y; Urata H; Hirawa N
    Hypertens Res; 2019 Sep; 42(9):1235-1481. PubMed ID: 31375757
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hypertension: The Points of Management of Hypertension for All Physicians--Based on the JSH 2014 Hypertension Guidelines--.Topics; III. Key points of antihypertensive treatment-life-style modification and drug therapy].
    Ishimitsu T; Ishikawa Y; Honda T
    Nihon Naika Gakkai Zasshi; 2015 Feb; 104(2):218-31. PubMed ID: 26571700
    [No Abstract]   [Full Text] [Related]  

  • 14. [Hypertension: The Points of Management of Hypertension for All Physicians--Based on the JSH 2014 Hypertension Guidelines--.Topics: II. Primary examinations for hypertensives].
    Shimosawa T
    Nihon Naika Gakkai Zasshi; 2015 Feb; 104(2):211-7. PubMed ID: 26571699
    [No Abstract]   [Full Text] [Related]  

  • 15. [Hypertension: The Points of Management of Hypertension for All Physicians--Based on the JSH 2014 Hypertension Guidelines--. Topics: VII. Key points for the management of hypertension in the elderly].
    Rakugi H
    Nihon Naika Gakkai Zasshi; 2015 Feb; 104(2):253-9. PubMed ID: 26571704
    [No Abstract]   [Full Text] [Related]  

  • 16. [Hypertension The Points of Management of Hypertension for All Physicians--Based on the JSH 2014 Hypertension Guidelines--. Topics: IX. Evaluation and management of hypertensive emergencies].
    Sakima A; Ohya Y
    Nihon Naika Gakkai Zasshi; 2015 Feb; 104(2):268-74. PubMed ID: 26571706
    [No Abstract]   [Full Text] [Related]  

  • 17. Antihypertensive efficacy of olmesartan medoxomil and candesartan cilexetil in achieving 24-hour blood pressure reductions and ambulatory blood pressure goals.
    Brunner HR; Arakawa K
    Clin Drug Investig; 2006; 26(4):185-93. PubMed ID: 17163250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Our mission in the Japanese Society of Hypertension (JSH) Future Plan: a baton-connection from JSH Osaka 2023 to Fukuoka 2024.
    Node K; Tanaka A
    Hypertens Res; 2024 May; 47(5):1097-1098. PubMed ID: 38485777
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of questionnaire responses regarding awareness of Japanese Society of Hypertension guidelines for the management of hypertension between 2014 and 2019 in primary care.
    Kobayashi K; Hatori N; Sakai H; Furuki T; Miyakawa M; Tamura K; Sato K; Kanamori A
    Hypertens Res; 2021 Sep; 44(9):1147-1157. PubMed ID: 34253880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ca antagonist in the guidelines for the management of hypertension (JSH 2004)].
    Umemura S
    Clin Calcium; 2005 Oct; 15(10):1599-608. PubMed ID: 16199904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.